Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
SVP, Strategy & Bus. Dev. · Envista Holdings Corp · Common Stock
Open-market sale
$220K reported value · 22.6% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Nilsson StefanPresident, Nobel Biocare | Tax withholding | F | $22K 804 sh | Aug 27, 2026 traded Aug 25, 2026 | |
| 16 | Acurio VeronicaPresident, Orthodontics | Tax withholding | F | $212K 7,710 sh | Aug 27, 2026 traded Aug 25, 2026 | |
| 16 | Befidi RobertPresident, Diagnostics | Tax withholding | F | $141K 5,147 sh | Aug 27, 2026 traded Aug 25, 2026 | |
| 9 | Acurio VeronicaPresident, Orthodontics | Tax withholding | F | $42K 1,412 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 9 | Nilsson StefanPresident, Nobel Biocare | Grant or award | A | — 13.8K sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 16 | Befidi RobertPresident, Diagnostics | Tax withholding | F | $64K 2,177 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 9 | Nilsson StefanPresident, Nobel Biocare | Tax withholding | F | $5,385 182 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 9 | Befidi RobertPresident, Diagnostics | Grant or award | A | — 18.0K sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 9 | Befidi RobertPresident, Diagnostics | Grant or award | A | — 13.8K sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 13 | Acurio VeronicaPresident, Orthodontics | Grant or award | A | — 7,605 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 9 | Acurio VeronicaPresident, Orthodontics | Grant or award | A | — 13.8K sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 9 | Acurio VeronicaPresident, Orthodontics | Grant or award | A | — 18.0K sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 13 | Befidi RobertPresident, Diagnostics | Grant or award | A | — 7,605 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 16 | Kaabi Faez CChief Accounting Officer | Tax withholding | F | $147K 4,964 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 17 | Kaabi Faez CChief Accounting Officer | Grant or award | A | — 13.5K sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 13 | Nilsson StefanPresident, Nobel Biocare | Grant or award | A | — 7,605 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 9 | Nilsson StefanPresident, Nobel Biocare | Grant or award | A | — 18.0K sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 17 | Kaabi Faez CChief Accounting Officer | Grant or award | A | $28K 1,186 sh | Feb 3, 2026 traded Feb 1, 2026 | |
| 21 | Befidi RobertPresident, Diagnostics | Grant or award | A | $23K 998 sh | Feb 3, 2026 traded Feb 1, 2026 | |
| 9 | Acurio VeronicaPresident, Orthodontics | Grant or award | A | $23K 998 sh | Feb 3, 2026 traded Feb 1, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $220,000
Reis Mischa filed this Form 4 reporting a open-market sale of NVST on Aug 20, 2026. It became public on Aug 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.